In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains

Microbial Drug Resistance

Volumn 14, Issue 2, 2008, Pages 151-153

  Kaya, Onur ^a,b   Akcam, Fusun Zeynep ^a   Temel, Esra Nurlu ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Modernevler Mahallesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; TIGECYCLINE; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; EPSILOMETER TEST; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; CLASSIFICATION; CROSS INFECTION; DRUG EFFECT; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PENICILLIN RESISTANCE; STANDARD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TURKEY (REPUBLIC);

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSIBACTERIA;

ACETAMIDES; ANTI-INFECTIVE AGENTS; CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TURKEY;

EID: 50149103302     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2008.0801     Document Type: Article

References (24)

1. Abb, J. 2002. In vitro activity of linezolid, quinupristin- dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the Etest and a broth microdilution method. Diagn. Microbiol. Infect. Dis. 43:319-321.
2. Betriu, C., M. Redondo, A. Boloix, M. Gomez, E. Culebras, and J.J. Picazo. 2001. Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J. Antimicrob. Chemother. 48:911-913.
3. Birmingham, M.C., C.R. Rayner, A.K. Meagher, S.M. Flavin, D.H. Batts, and J.J. Schentag. 2003. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin. Infect. Dis. 36:159-168.
4. Bouchillon, S.K., D.J. Hoban, B.M. Johnson, T.M. Stevens, M.J. Dowzicky, D.H. Wu, and P.A. Bradford. 2005. In vitro evaluation of tygecycline and comparative agents in 3049 clinical isolates: 2001 to 2002. Diagn. Microbiol. Infect. Dis. 51:291-295.
5. Clinical and Laboratory Standards Institute (CLSI). 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. M100-S15. Wayne, PA.
6. Denis, O., A. Deplano, C. Nonhoff, M. Hallin, R. De Ryck, R. Vanhoof, R. De Mendonça, and M.J. Struelens. 2006. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob. Agents Chemother. 50:2680-2685.
7. Diekema, D.J., and R.N. Jones. 2001. Oxazolidinone antibiotics. Lancet 358:1975-1982.
8. Garrison, M.W., and J.J. Nuemiller. 2007. In vitro activity of tygecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Int. J. Antimicrob. Agents 29:191-196.
9. Haddadin, A.S., S.A. Fappiano, and P.A. Lipsett. 2002. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 78:385-392.
10. Livermore, D.M. 2003. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 51 Suppl: 2ii9-2ii16.
11. Livermore, D.M. 2000. Antibiotic resistance in staphylococci. Int. J. Antimicrob. Agents 16 Suppl 1:S3-S10.
12. Livermore, D.M. 2000. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J. Antimicrob. Chemother. 46:347-350.
13. Milatovic, D., F.J. Schmitz, J. Verhoef, and A.C. Fluit. 2003. Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob. Agents Chemother. 47:400-404.
14. Moellering, R.C. 2003. Linezolid: the first oxazolidinone antimicrobial. Ann. Intern. Med. 138:135-142.
15. Moreillon, P., Y. Que, and M.P. Glauser. 2005. Staphylococcus aureus. In G.L. Mandell, J.E. Bennett, and R. Dolin (eds.), Principles and practice of infectious diseases, 6th ed. Elsevier, Philadelphia, pp. 2321-2351.
16. Nakipoglu, Y., S. Derbentli, A.A. Caǧatay, and H. Katranci. 2005. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital. BMC Infect. Dis. 5:31.
17. Nathwani, D. 2005. Tigecycline: clinical evidence and formulary positioning. Int. J. Antimicrob. Agents 25:185-192.
18. Samra, Z., O. Ofer, and H. Shmuely. 2005. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Isr. Med. Assoc. J. 7:148-150.
19. Sancak, B., S. Ercis, D. Menemenlioglu, S. Colakoglu, and G. Hascelik. 2005. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J. Antimicrob. Chemother. 56:519-523.
20. Silvia Munoz-Price, L., K. Lolans, and J.P. Quinn. 2006. Four cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections treated with tigecycline. Scand. J. Infect. Dis. 38:1081-1084.
21. Stein, G.E., and W.A. Craig. 2006. Tigecycline: a critical analysis. Clin. Infect. Dis. 43:518-524.
22. Tiwari, H.K., and M.R. Sen. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 26:156.
23. Townsend, M.L., M.W. Pound, and L.H. Drew. 2006. Tigecycline: a new glycycline antimicrobial. Int. J. Clin. Pract. 60:1662-1672.
24. Van Griethuysen, A., A. Van't Veen, A. Buiting, T. Walsh, and I. Kluytmans. 2003. High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in the Netherlands. J. Clin. Microbiol. 41:2487-2491.